Ensol Biosciences Inc. Stock

Ensol Biosciences Inc is a Korea-based company primarily engaged in the research and development of pharmaceuticals. The Company is engaged in the research and development of 'Peniel2000' (P2K) for degenerative disc disease, 'P2K' indication expansion, 'Engedi1000' (E1K) for knee osteoarthritis, and anticancer combination therapy. The Company is also engaged in the research and development of canine osteoarthritis therapy, 'Moriah1000' (M1K) for alzheimer’s disease (AD), and 'Hadassah1000' (H1K) for oral obesity treatment. In addition, the Company is engaged in the provision of services such as synthesis and purification services, and consulting on of breeding information systems.